dormakaba has announced a notable increase in project acquisitions within the healthcare industry for the 2025/26 fiscal year.
Aligned with their strategic market approach, the company has successfully secured various contracts across Norway, Germany, and the United States.
These projects serve to bolster dormakaba's commitment to its healthcare division, focusing on solutions for doors including locks, door hardware, door automation, access control, and mechanical locking systems. The overall order value rests in the low double-digit million range (CHF).
Key Projects Secured in Norway, Germany, and the US
In Norway, the South-Eastern Norway Regional Health Authority has entrusted dormakaba with a substantial contract involving over 5,500 doors as part of the New Aker hospital initiative. This project stands among the largest construction efforts within Norway's healthcare sector, slated for completion by 2031.
Germany's m&i-Klinikgruppe Enzensberg has similarly engaged dormakaba for a multi-location project, covering more than 4,500 doors across various rehabilitation centers. The endeavor requires compliance with the European Union’s NIS2 cybersecurity standards, underscoring advanced access control measures.
In the United States, dormakaba's New York Entrance Systems team has forged strategic alliances with two prominent healthcare systems in New York. The partnerships encompass entrance system services and refurbishments, alongside expanded cooperation in security, access control, and ongoing support. These agreements further cement dormakaba's reputation as a reliable partner within the US healthcare market.
Escalating Demand for Secure Access Solutions
Till Reuter, CEO of dormakaba, expressed the company's growing success: “Demand for our solutions in the healthcare sector is high, and our business is gaining momentum. These recent project wins demonstrate the growing demand for secure, efficient, and innovative access solutions. We are proud to support leading healthcare providers as their trusted partner. These orders further reinforce our position in the healthcare market and support our ongoing growth in this sector.”
